GLOW

Pack of 10 × 70mg powder vials in a protective case

Enlarge

Price · per pack

£535.00

Available to order

£750.00 Save £215.00 (29%)

£53.50 per vial · 10 vials per case

Free delivery £50+ Royal Mail Tracked 24

Estimated dispatch: 10-15 working days. Dispatch follows availability.

Batch documentation

COA not yet available. Ask about documentation →

Explore research & studies

Product overview & specifications

GLOW in 10-vial case. Check the product record for the stated strength, storage information and batch-document availability.

Strength: 70mg × 10 vials
Presentation: 10-vial case
Batch documentation: availability shown on this listing

Strength70mg × 10 vials

Presentation10-vial case

Purity99%+

Storage2-8 C

Part number: BBG70-10PK
Storage: Store refrigerated at 2-8 C, protected from light.
COA: Added to your account when available
Delivery: Royal Mail Tracked 24 is £4.95, or free on merchandise subtotals of £50+; Estimated dispatch: 10-15 working days
Tracking: Emailed once dispatched and shown in your profile
Contents: 10-vial case
Status: Research use only

For laboratory research only

For laboratory research use only. Not for human or veterinary use. No use instructions or medical guidance is provided. Understand COA documentation.

Research information

GLOW research profile

What is being studied?

GLOW is a documented combination of three research components rather than a single molecular entity. It combines a copper-binding tripeptide complex with BPC-157 and supplier-designated TB500 material.

The preparation supports blend-versus-component comparison across extracellular-matrix, cell-migration and thymosin-beta-related actin models. Published component findings do not establish one unified mechanism for the blend.

Research areas

Blend identity and component-consistency analysis
Extracellular-matrix and fibroblast response models
Cell-migration and actin-pathway comparison assays

Selected studies

Cell study · 2000
GHK-Cu and extracellular-matrix measurements ↗
Measured MMP-2 and tissue-inhibitor responses in fibroblast cultures exposed to GHK-Cu.
Cell and tissue study · 2011
BPC-157 and fibroblast migration ↗
Investigated BPC-157 in rat tendon explants and cultured fibroblasts; it did not test a combined blend.
Thymosin beta-4 binding to actin ↗

How to read this research

These papers study defined compounds in specific experimental systems or clinical trials. They do not test or certify this product, its batch or its prepared presentation. Component and related-peptide studies do not establish the effects of a finished blend. Findings are research context, not evidence of safety or suitability for personal use. For laboratory research only; no treatment, dosing or use advice is provided.

Technical product record

GLOW research record

Molecular identity and stated sequence or composition, alongside the batch, storage, dispatch and document record for this 10-vial case.

Molecular identity

Three-component peptide research blend

Sequence / composition

50mg GHK-Cu + 10mg BPC-157 + 10mg TB500

Product record

The listing identifies the presentation, specification, storage record, dispatch status, and batch-document availability for the relevant product or batch.

Use restriction

For laboratory research use only. Not for human or veterinary consumption. No use instructions or therapeutic guidance is provided.